维普中文期刊产品整合服务
566篇 您的检索式:作者名="Galluzzi"
    题名 作者 年代 出处 被引量
1Mitochondrial metabolism and cancer显示文摘Glycolysis 长在癌症房间为精力生产和 anabolism 的生长被看作了主要新陈代谢的过程。尽管如此的一个看法为仍然在诊所被使用的强大的成像工具的发展是有帮助的,线粒体在 oncogenesis 起一个关键作用,现在是清楚的。除施加中央 bioenergetic 函数以外,线粒体确实为肿瘤同化提供积木,控制氧化还原作用和钙动态平衡,参予 transcriptional 规定,并且管理房间死亡。因此,线粒体为新奇 anticancer 代理人的发展组成有希望的目标。然而,肿瘤产生,进行,并且回答功能依靠未经触动的 mitochondrial 新陈代谢到在有主人免疫系统,和许多免疫学的亲密串音的上下文的治疗。这里,我们考察房间内在的癌症和线粒体影响都 oncogenesis 通过走的房间外来的机制,与指向为癌症治疗的 mitochondrial 新陈代谢的治疗学的潜力的一个焦点。Paolo Ettore Porporato Nicoletta Filigheddu José Manuel Bravo-San Pedro, Guido Kroemer, Lorenzo Galluzzi José Manuel Bravo-San Pedro, Guido Kroemer José Manuel Bravo-San Pedro, Guido Kroemer José Manuel Bravo-San Pedro, Guido Kroemer José Manuel Bravo-San Pedro, Guido Kroemer Guido Kroemer Guido Kroemer Lorenzo Galluzzi Lorenzo Galluzzi 2018Cell Research2018,28,3:33
2MLKL regulates necrotic plasma membrane permeabilization显示文摘Lorenzo Galluzzi 2014Cell Research2014,24,2:12
3Calreticulin and cancer显示文摘Calreticulin(CALR)is an endoplasmic reticulum(ER)-resident protein involved in a spectrum of cellular processes.In healthy cells,CALR operates as a chaperone and Ca^(2+)buffer to assist correct protein folding within the ER.Besides favoring the maintenance of cellular proteostasis,these cell-iintrinsic CALR functions support Ca^(2+)-dependent processes,such as adhesion and integrin signaling,and ensure normal antigen presentation on MHC Class I molecules.Moreover,cancer cells succumbing to immunogenic cell death(ICD)expose CALR on their surface,which promotes the uptake of cell corpses by professional phagocytes and ultimately supports the initiation of anticancer immunity.Thus,loss-of-function CALR mutations promote oncogenesis not only as they impair cellular homeostasis in healthy cells,but also as they compromise natural and therapy-driven immunosurveillanee.However,the prognostic impact of total or membrane-exposed CALR levels appears to vary considerably with cancer type.For instance,while genetic CALR defects promote pre-neoplastic myeloproliferation,patients with myeloproliferative neoplasms bearing CALR mutations often experience improved overall survival as compared to patients bearing wild-type CALR.Here,we discuss the context-dependent impact of CALR on malignant transformation,tumor progression and response to cancer therapy.Jitka Fucikova Radek Spisek Guido Kroemerc Lorenzo Galluzzi 2021Cell Research2021,31,1:12
4Mechanisms of p53-mediated mitochondrial membrane permeabilization显示文摘Eugenia Morselli 2008Cell Research2008,18,7:3
5Editing the Shape Morphing of Monocomponent Natural Polysaccharide Hydrogel Films显示文摘Shape-morphing hydrogels can be widely used to develop artificial muscles,reconfigurable biodevices,and soft robotics.However,conventional approaches for developing shape-morphing hydrogels highly rely on composite materials or complex manufacturing techniques,which limit their practical applications.Herein,we develop an unprecedented strategy to edit the shape morphing of monocomponent natural polysaccharide hydrogel films via integrating gradient cross-linking density and geometry effect.Owing to the synergistic effect,the shape morphing of chitosan(CS)hydrogel films with gradient cross-linking density can be facilely edited by changing their geometries(length-to-width ratios or thicknesses).Therefore,helix,short-side rolling,and longside rolling can be easily customized.Furthermore,various complex artificial 3D deformations such as artificial claw,horn,and flower can also be obtained by combining various flat CS hydrogel films with different geometries into one system,which can further demonstrate various shape transformations as triggered by pH.This work offers a simple strategy to construct a monocomponent hydrogel with geometry-directing programmable deformations,which provides universal insights into the design of shape-morphing polymers and will promote their applications in biodevices and soft robotics.Hao Hu Chao Huang Massimiliano Galluzzi Qiang Ye Rui Xiao Xuefeng Yu Xuemin Du 2021Research2021,,1:3
6Immunogenic Cell Death in Cancer Therapy显示文摘Guido Kroemer Lorenzo Galluzzi Oliver Kepp Laurence Zitvogel 2013Annual Review of Immunology2013,,:2
7Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance显示文摘Laurence Zitvogel Lorenzo Galluzzi Mark J. Smyth Guido Kroemer 2013Immunity2013,,1:2
8FADD: an endogenous inhibitor of RIP3-driven regulated necrosis显示文摘Lorenzo Galluzzi Oliver Kepp Guido Kroemei 2011Cell Research2011,21,10:2
9Distinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease 显示文摘Galluzzi S Sheu CF Zanetti O 2005Dement Geriatr Cogn2005,19,:1
10Management Strategies for Herpes Zoster and Postherpetic Neuralgia显示文摘 Galluzzi DO 2007J Am Osteopath Assoc2007,1073,:1
11Necroptosis:a specialized pathway of programmed necrosis 显示文摘Galluzzi L Kroemer G 2008Cell2008,135,7:1
12Necroptosis :A specialized pathway of programmed necrosis显示文摘Galluzzi L Kroemer G 2008Cell2008,135,7:1
13Regulation of autophagy by cytoplasmic p53 显示文摘Tasdemir E Maiuri MC Galluzzi L 2008Nat Cell Biol2008,10,6:1
14Classification of cell death : recommendations of the Nomenclature Committee on Cell Death 2009 显示文摘Kroemer G Galluzzi L Vandenabeele P 2009Cell Death Differ2009,16,1:1
15Mild cognitive impairment with subcortical vascular features : clinical characteristics and outcome显示文摘Frisoni GB Galluzzi S Bresciani L 2002J Neurol2002,249,10:1
16Topical therapies in the management pain显示文摘Stanos 8P Galluzzi KE 2015Postgrad Meal2015,125,41:1
17Mitochondrial membrane permeabilization in cell death 显示文摘Kroemer G Galluzzi L Brenner C 2007Physiol Rev2007,87,1:1
18Caspase-3 and prostaglandinssignal for tumor regrowth in cancer therapy显示文摘Galluzzi L Kepp O Kroemer G 2012Oncogene2012,31,23:1
19Targeting mitochondria for cancer therapy 显示文摘Fulda S Galluzzi L Kroemer G 2010Nat Rev Drug Discov2010,9,6:1
20Hippocampal and amyg- dalar volume changes in elderly patients with Alzheimer's disease and schizophrenia显示文摘Prestia A Boccardi M Galluzzi S 2011Psychiatry Res2011,192,:1
返回顶部 每页显示:
共29页 首页 上一页 第1页 下一页 末页 /29 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费